Sanofi and Lonza have entered into a strategic partnership to build and operate a large-scale mammalian cell culture facility.
The facility, to be built in Visp, Switzerland, will be established through a joint venture with an initial investment of around CHF290m shared equally between Sanofi and Lonza.
Jones & Day and Walder Wyss acted as legal counsels to Sanofi in this matter.
The Walder Wyss team included Luc Defferrard (partner, M&A), Michael Isler (partner, IPIT), Ramona Wyss (managing associate, M&A IPIT), Tina Hurni (associate, real estate) and Alexandra Brenner (associate, real estate).
The post Walder Wyss assists on Sanofi and Lonza joint venture appeared first on The Lawyer | Legal News and Jobs | Advancing the business of law.